Alan Barge

Director/Board Member at THERACRYF PLC

Health Technology

Health Services

Consumer Services

Profile

Alan Barge was the founder of ASLAN Pharmaceuticals Pte Ltd., founded in 2016, where the title held was Senior Vice President-Oncology.
Current jobs include Chief Executive Officer at Tilikum Therapeutics, Inc. since 2023; Director at West Thorpe (2011) Ltd.; Director & Investor Director at Oribiotech Ltd.; Senior Independent Non-executive Director at TheraCryf Plc since 2024; and Venture Partner at Delin Ventures Ltd. since 2019.
Former jobs include Chairman-Supervisory Board at Modra Pharmaceuticals BV; Global Medical Director-European at Amgen, Inc. from 1990 to 1998; Vice President-Clinical & Head-Oncology at AstraZeneca PLC from 2009 to 2010; and Chief Medical Officer at Oncoinvent ASA from 2018 to 2019.
Education includes graduation from the University of Oxford in 1983.

Alan Barge active positions

Companies	Position	Start
THERACRYF PLC	Director/Board Member	2015-10-13
West Thorpe (2011) Ltd.	Director/Board Member	-
Oribiotech Ltd. Oribiotech Ltd. BiotechnologyHealth Technology Develops and manufactures cell and gene therapy	Chief Investment Officer	-
Delin Ventures Ltd. Delin Ventures Ltd. Investment ManagersFinance Delin Ventures invests in companies located in Europe, primarily in the United Kingdom, Germany, Austria, and Switzerland. The firm targets companies operating in the fields of life sciences and manufacturing technologies sectors. It provides financing for pre-seed, seed and early stage capital requirements with an investment size of EUR 0.5 - 2 million.	Private Equity Investor	2019-02-28
Tilikum Therapeutics Tilikum Therapeutics Hospital/Nursing ManagementHealth Services Provides cancer treatment services	Chief Executive Officer	2022-12-31

All active positions of Alan Barge

Former positions of Alan Barge

Companies	Position	End
ONCOINVENT ASA	Chief Tech/Sci/R&D Officer	2019-03-12
ASTRAZENECA PLC	Corporate Officer/Principal	2010-11-30
AMGEN INC.	Corporate Officer/Principal	1998-08-31
Modra Pharmaceuticals BV Modra Pharmaceuticals BV Pharmaceuticals: MajorHealth Technology Designs and develops oral formulations of commonly used anti-cancer drugs	Chairman	-
░░░░░ ░░░░░░░░░░░░░░░ ░░░ ░░░░	░░░░░░░	-

See the detail of Alan Barge's experience

Training of Alan Barge

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Alan Barge's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	11
Amgen, Inc. Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics	Health Technology
AstraZeneca PLC AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Health Technology
Evgen Pharma Plc Evgen Pharma Plc Medical/Nursing ServicesHealth Services Engages in the development of pharmaceutical products and focus on cancer & neurological disease	Health Services
University of Oxford University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
BerGenBio ASA BerGenBio ASA Pharmaceuticals: MajorHealth Technology Develops drugs for aggressive, drug resistant cancers	Health Technology
ASLAN Pharmaceuticals Pte Ltd. ASLAN Pharmaceuticals Pte Ltd. BiotechnologyHealth Technology Develops novel medicines for global markets	Health Technology
West Thorpe (2011) Ltd.
Modra Pharmaceuticals BV Modra Pharmaceuticals BV Pharmaceuticals: MajorHealth Technology Designs and develops oral formulations of commonly used anti-cancer drugs	Health Technology
Delin Ventures Ltd. Delin Ventures Ltd. Investment ManagersFinance Delin Ventures invests in companies located in Europe, primarily in the United Kingdom, Germany, Austria, and Switzerland. The firm targets companies operating in the fields of life sciences and manufacturing technologies sectors. It provides financing for pre-seed, seed and early stage capital requirements with an investment size of EUR 0.5 - 2 million.	Finance
Oribiotech Ltd. Oribiotech Ltd. BiotechnologyHealth Technology Develops and manufactures cell and gene therapy	Health Technology
Tilikum Therapeutics Tilikum Therapeutics Hospital/Nursing ManagementHealth Services Provides cancer treatment services	Health Services

See company connections